[1]
“Stability-indicating Reversed Phase-Ultra Performance Liquid Chromatography Method Development and Validation for Simultaneous Determination of Encorafenib and Binimetinib in Formulation”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 5, pp. 488–494, Sep. 2020, doi: 10.25004/IJPSDR.2020.120509.